Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
Status:
Recruiting
Trial end date:
2022-03-30
Target enrollment:
Participant gender:
Summary
This phase IB trial is studying how well giving gemcitabine together with Z650 works in
treating patients with metastatic or recurrent pancreatic cancer.